Back to search
FDAFDA · Food and drugs·Recall number Z-0215-2019

STREAMLAB CORE UNIT / LYNX WITH IOM

Published October 31, 2018 · Recall initiated: August 14, 2018

Summary

FDA records medical device Class II recall Z-0215-2019, published October 31, 2018 and initiated August 14, 2018. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Terminated; Reported quantity: 186 StreamLAB Automation Modules; Lot: Siemens Material Numbers: 10444806; UDI: 00630414949765. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The modules may have been shipped without a warning label for potential risk of interference to pacemaker functionality.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc.
Distributor
The products were distributed to the following US states: AL, AR, AZ, CA, CO, CT, DE, FL, GA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, PA, SC, TN, TX, VA, WA, and WV. The products were distributed to the following foreign countries: Australia, Austria, Bangladesh, Belgium, Canada, Croatia, France, Germany, Greece, Hong Kong, India, Indonesia, Italy, Libya, Netherlands, Philippines, Portugal, Saudi Arabia, Slovakia, Slovenia, Spain, Taiwan, Thaliand, UAE, UK.
Lot
Siemens Material Numbers: 10444806; UDI: 00630414949765
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was STREAMLAB CORE UNIT / LYNX WITH IOM recalled?

Yes. FDA published recall Z-0215-2019 on October 31, 2018. Reported hazard: The modules may have been shipped without a warning label for potential risk of interference to pacemaker functionality.

What should I do if I have this product?

Voluntary: Firm initiated · Letter